UL Cell | The Autologous Regeneration Company™
No donors. No genes. No editing. Just repair.
UL Cell is building the infrastructure for regenerative medicine without donors, genetic modification, or centralized manufacturing.
We enable patient-derived cell repair through a modular system — now in stealth and scaling globally.
Headquartered in Singapore.
www.ulcell.bio | Contact: Jeff.low@acn.ventures
Company Details
- Employees
- 2
- Founded
- -
- Address
- Singapore, --- None ---, Sg
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Hematology, Autologous HCTs therapies, Gene therapies), Oncology, Osteogenic, Adipogenic, Chondrogenic, Neurogenic, Myogenic, Cardiomyocytes, Pancreatic cells, Hepatocytes.
- HQ
- Singapore, --- None ---
- Competitors
- Angitia Biopharmaceuticals, ACN Holdings Co. Ltd, Femeraid International, ChatEdu.AI, Knights of Malta (Asia) Sovereign State. Federation of Autonomous Priories of St.John, 宣捷幹細胞生技, Society for Aviation Research and Development in Asia | SARDA, Officinae Bio, part of Maravai LifeSciences, STADA Österreich, PBL Assay Science.
Ul Cell Therapeutic | The Autologous Regeneration Company™ Questions
Ul Cell Therapeutic | The Autologous Regeneration Company™'s LinkedIn profile is https://www.linkedin.com/company/ul-cell-therapeutic
Ul Cell Therapeutic | The Autologous Regeneration Company™ has
2 employees.
View email and phone details for 2
employees at Ul Cell Therapeutic | The Autologous Regeneration Company™.
Ul Cell Therapeutic | The Autologous Regeneration Company™'s industry is
Biotechnology Research
Ul Cell Therapeutic | The Autologous Regeneration Company™'s top competitors are
Angitia Biopharmaceuticals,
Acn Holdings Co. Ltd,
Femeraid International,
Chatedu.ai,
Knights Of Malta (Asia) Sovereign State. Federation Of Autonomous Priories Of St.john,
宣捷幹細胞生技,
Society For Aviation Research And Development In Asia | Sarda,
Officinae Bio, Part Of Maravai Lifesciences,
Stada Österreich,
Pbl Assay Science.
Ul Cell Therapeutic | The Autologous Regeneration Company™'s categories are Biotechnology Research
Ul Cell Therapeutic | The Autologous Regeneration Company™'s founding year is 2022
